Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2006 1
2007 1
2008 1
2009 3
2010 1
2011 4
2012 3
2013 1
2014 2
2015 3
2016 4
2017 1
2018 3
2019 3
2020 12
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

39 results
Results by year
Filters applied: . Clear all
Page 1
Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol.
Bielawiec P, Harasim-Symbor E, Chabowski A. Bielawiec P, et al. Front Endocrinol (Lausanne). 2020 Mar 4;11:114. doi: 10.3389/fendo.2020.00114. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32194509 Free PMC article. Review.
Currently, an increasing number of diseases related to insulin resistance and obesity is an alarming problem worldwide. It is well-known that the above states can lead to the development of type 2 diabetes, hypertension, and cardiovascular diseases. ...CBD is considered as …
Currently, an increasing number of diseases related to insulin resistance and obesity is an alarming problem worldwide. It is well-kn …
Endocannabinoid System: A Multi-Facet Therapeutic Target.
Kaur R, Ambwani SR, Singh S. Kaur R, et al. Curr Clin Pharmacol. 2016;11(2):110-7. doi: 10.2174/1574884711666160418105339. Curr Clin Pharmacol. 2016. PMID: 27086601 Review.
Several diseases like emesis, pain, inflammation, multiple sclerosis, anorexia, epilepsy, glaucoma, schizophrenia, cardiovascular disorders, cancer, obesity, metabolic syndrome related diseases, Parkinson's disease, Huntington's disease, Alzheimer's di …
Several diseases like emesis, pain, inflammation, multiple sclerosis, anorexia, epilepsy, glaucoma, schizophrenia, cardiovascular disorders, …
Cannabidiol promotes browning in 3T3-L1 adipocytes.
Parray HA, Yun JW. Parray HA, et al. Mol Cell Biochem. 2016 May;416(1-2):131-9. doi: 10.1007/s11010-016-2702-5. Epub 2016 Apr 11. Mol Cell Biochem. 2016. PMID: 27067870
The present study was designed to investigate the effects of cannabidiol (CBD), a major nonpsychotropic phytocannabinoid of Cannabis sativa, on induction of browning in 3T3-L1 adipocytes. ...Thus, CBD may be explored as a potentially promising therapeutic agent for the pre …
The present study was designed to investigate the effects of cannabidiol (CBD), a major nonpsychotropic phytocannabinoid of Cannabis …
Experimental cannabidiol treatment reduces early pancreatic inflammation in type 1 diabetes.
Lehmann C, Fisher NB, Tugwell B, Szczesniak A, Kelly M, Zhou J. Lehmann C, et al. Clin Hemorheol Microcirc. 2016;64(4):655-662. doi: 10.3233/CH-168021. Clin Hemorheol Microcirc. 2016. PMID: 27767974 Clinical Trial.
BACKGROUND: Destruction of the insulin-producing beta cells in type 1 diabetes (T1D) is induced by invasion of immune cells causing pancreatic inflammation. Cannabidiol (CBD), a phytocannabinoid, derived from the plant, Cannabis sativa, was shown to lower the incidence of …
BACKGROUND: Destruction of the insulin-producing beta cells in type 1 diabetes (T1D) is induced by invasion of immune cells causing pancreat …
A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain.
Verrico CD, Wesson S, Konduri V, Hofferek CJ, Vazquez-Perez J, Blair E, Dunner K Jr, Salimpour P, Decker WK, Halpert MM. Verrico CD, et al. Pain. 2020 Sep 1;161(9):2191-2202. doi: 10.1097/j.pain.0000000000001896. Pain. 2020. PMID: 32345916
Over the last 2 decades, affirmative diagnoses of osteoarthritis (OA) in the United States have tripled due to increasing rates of obesity and an aging population. Hemp-derived cannabidiol (CBD) is the major nontetrahydrocannabinol component of cannabis and has been …
Over the last 2 decades, affirmative diagnoses of osteoarthritis (OA) in the United States have tripled due to increasing rates of obesit …
GPR3, GPR6, and GPR12 as novel molecular targets: their biological functions and interaction with cannabidiol.
Laun AS, Shrader SH, Brown KJ, Song ZH. Laun AS, et al. Acta Pharmacol Sin. 2019 Mar;40(3):300-308. doi: 10.1038/s41401-018-0031-9. Epub 2018 Jun 25. Acta Pharmacol Sin. 2019. PMID: 29941868 Free PMC article. Review.
Using beta-arrestin2 recruitment and cAMP accumulation assays, we recently found that the nonpsychoactive phytocannabinoid cannabidiol (CBD) is an inverse agonist for GPR3, GPR6, and GPR12. This discovery highlights these orphan receptors as potential new molecular targets …
Using beta-arrestin2 recruitment and cAMP accumulation assays, we recently found that the nonpsychoactive phytocannabinoid cannabidiol …
A Case of Toxicity from Cannabidiol Gummy Ingestion.
Bass J, Linz DR. Bass J, et al. Cureus. 2020 Apr 16;12(4):e7688. doi: 10.7759/cureus.7688. Cureus. 2020. PMID: 32431968 Free PMC article.
A 56-year-old male with no known history of substance abuse and no known prior medical conditions presented via ambulance to the emergency department after being found by coworkers with bizarre behavior, vomiting, and slurred speech. He had legally purchased cannabidiol (C …
A 56-year-old male with no known history of substance abuse and no known prior medical conditions presented via ambulance to the emergency d …
Vasodilatory effects of cannabidiol in human pulmonary and rat small mesenteric arteries: modification by hypertension and the potential pharmacological opportunities.
Baranowska-Kuczko M, Kozłowska H, Kloza M, Sadowska O, Kozłowski M, Kusaczuk M, Kasacka I, Malinowska B. Baranowska-Kuczko M, et al. J Hypertens. 2020 May;38(5):896-911. doi: 10.1097/HJH.0000000000002333. J Hypertens. 2020. PMID: 31800399 Free PMC article.
OBJECTIVE: Cannabidiol (CBD) has been suggested as a potential antihypertensive drug. ...CONCLUSION: The CBD-induced relaxation in hPAs that was reduced in hypertensive, obese and hypercholesteremic patients was endothelium-dependent and mediated via KCa and IP, EP4 …
OBJECTIVE: Cannabidiol (CBD) has been suggested as a potential antihypertensive drug. ...CONCLUSION: The CBD-induced relaxation in hP …
Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders.
Galaj E, Xi ZX. Galaj E, et al. CNS Drugs. 2019 Oct;33(10):1001-1030. doi: 10.1007/s40263-019-00664-w. CNS Drugs. 2019. PMID: 31549358 Free PMC article. Review.
Significant progress was made with the discovery of rimonabant, a selective CB1 receptor (CB1R) antagonist (also an inverse agonist), as a promising therapeutic for SUDs and obesity. However, serious adverse effects such as depression and suicidality led to the withdrawal …
Significant progress was made with the discovery of rimonabant, a selective CB1 receptor (CB1R) antagonist (also an inverse agonist), as a p …
39 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page